Teladoc Health, Inc. (NYSE:TDOC) Shares Acquired by Versant Capital Management Inc

Versant Capital Management Inc boosted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 313.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,219 shares of the health services provider’s stock after purchasing an additional 2,441 shares during the quarter. Versant Capital Management Inc’s holdings in Teladoc Health were worth $29,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in TDOC. Bank of New York Mellon Corp grew its holdings in Teladoc Health by 1.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 916,129 shares of the health services provider’s stock worth $8,960,000 after buying an additional 14,910 shares in the last quarter. Principal Financial Group Inc. boosted its position in Teladoc Health by 27.8% during the 2nd quarter. Principal Financial Group Inc. now owns 17,674 shares of the health services provider’s stock worth $173,000 after acquiring an additional 3,841 shares during the period. Rhumbline Advisers grew its stake in shares of Teladoc Health by 62.9% in the second quarter. Rhumbline Advisers now owns 276,535 shares of the health services provider’s stock worth $2,704,000 after purchasing an additional 106,770 shares in the last quarter. Arizona State Retirement System increased its holdings in shares of Teladoc Health by 4.2% during the second quarter. Arizona State Retirement System now owns 47,400 shares of the health services provider’s stock valued at $464,000 after purchasing an additional 1,901 shares during the period. Finally, Acadian Asset Management LLC raised its stake in shares of Teladoc Health by 391.4% during the second quarter. Acadian Asset Management LLC now owns 32,607 shares of the health services provider’s stock valued at $318,000 after purchasing an additional 25,971 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

Insider Activity

In related news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.95% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on TDOC. Evercore ISI raised their target price on shares of Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. The Goldman Sachs Group started coverage on Teladoc Health in a report on Friday, November 15th. They set a “buy” rating and a $14.00 target price on the stock. TD Cowen decreased their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research note on Thursday, October 31st. Deutsche Bank Aktiengesellschaft lifted their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Finally, Barclays upped their price objective on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Fourteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Teladoc Health has a consensus rating of “Hold” and a consensus target price of $12.24.

Teladoc Health Stock Up 0.5 %

TDOC stock opened at $9.98 on Wednesday. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The firm has a market cap of $1.72 billion, a PE ratio of -1.73 and a beta of 1.01. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $22.16. The company has a fifty day simple moving average of $9.92 and a 200 day simple moving average of $9.03.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.10. The company had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Sell-side analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.